SENSITIVITY AND SELECTIVITY OF RICIN TOXIN-A CHAIN MONOCLONAL-ANTIBODY 791T/36 CONJUGATES AGAINST HUMAN-TUMOR CELL-LINES
- 1 November 1986
- journal article
- research article
- Vol. 46 (11) , 5524-5528
Abstract
Ricin toxin A chain (RTA) was conjugated to monoclonal antibody 791T/36, which was raised originally against human osteogenic sarcoma cell line 791T. The resultant conjugates were characterized and tested for cytotoxicity against a panel of human tumor cell lines representing a defined range of antigenicity with regard to 791T/36. Conjugates were highly cytotoxic for cells expressing high antigen density, inhibiting cell survival at RTA concentrations three to four orders of magnitude lower than that possible with RTA alone. Cytotoxicity of conjugates diminished with decreasing 791T/36 antigen concentration on target cells, but significant effects were seen against cells of low or intermediate antigenicity. Cytotoxicity could be blocked specifically by excess 791T/36 antibody, clearly indicating that antigen binding was a necessary part of the mechanism of action. Comparison with drug-antibody conjugates indicated that RTA immunotoxins are much more active, but discriminate less readily than drug-antibody conjugates between cells of different antigenicity. It is suggested that these properties be taken into account with regard to practical application and future development.This publication has 11 references indexed in Scilit:
- Kinetics of divalent monoclonal antibody binding to tumour cell surface antigens using flow cytometry: Standardization and mathematical analysisMolecular Immunology, 1985
- Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.The Journal of Immunology, 1984
- Preparation of four daunomycin‐monoclonal antibody 79IT/36 conjugates with anti‐tumour activityInternational Journal of Cancer, 1984
- Antigenicity and drug susceptibility of human osteogenic sarcoma cells “escaping” a cytotoxic methotrexate-albumin-monoclonal antibody conjugateBritish Journal of Cancer, 1984
- Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells.Proceedings of the National Academy of Sciences, 1983
- Preparation and properties of a drug‐carrier‐antibody conjugate showing selective antibody‐directed cytotoxicity in vitroInternational Journal of Cancer, 1983
- Selective cytotoxicity against human tumour cells by a vindesine-monoclonal antibody conjugateBritish Journal of Cancer, 1983
- Antitumour reactions of monoclonal antibody against a human osteogenic-sarcoma cell lineBritish Journal of Cancer, 1981
- Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin.Proceedings of the National Academy of Sciences, 1980
- Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells.Proceedings of the National Academy of Sciences, 1980